Who we are
Lead Pharma is a clinical-stage pharmaceutical research & development company. We design and develop innovative small-molecule therapies to treat autoimmune diseases and cancer.
Our team of R&D professionals offers a wealth of experience in numerous areas of drug discovery, from target identification through lead optimization to pre-clinical development.
We have a proven track record of discovering, designing, and delivering pre-clinical and clinical stage candidate drugs.
Our ambition is to develop life-changing treatments for patients.
For patients with cancer, our therapies target primary tumors, metastasis, treatment resistance, refractory tumors, and tumors for which the only treatment option is chemotherapy.
For patients with autoimmune diseases, we aim to improve the lives of patients suffering from debilitating diseases, with a focus on oral therapies that have good efficacy and a clean safety profile.